gadolinium oxide has been researched along with Brain Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baek, MJ; Chae, KS; Chang, Y; Choi, ES; Jung, JC; Kim, JH; Kim, TJ; Lee, GH; Park, JY; Woo, S | 1 |
| Faucher, L; Fortin, MA; Gossuin, Y; Lagueux, J; Tremblay, M | 1 |
2 other study(ies) available for gadolinium oxide and Brain Neoplasms
| Article | Year |
|---|---|
Paramagnetic ultrasmall gadolinium oxide nanoparticles as advanced T1 MRI contrast agent: account for large longitudinal relaxivity, optimal particle diameter, and in vivo T1 MR images.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Contrast Media; Gadolinium; Glucuronic Acid; Humans; Injections; Magnetic Resonance Imaging; Magnetics; Nanoparticles; Particle Size; Protons; Rats; Spectroscopy, Fourier Transform Infrared; Surface Properties; Thermogravimetry; Water | 2009 |
Rapid synthesis of PEGylated ultrasmall gadolinium oxide nanoparticles for cell labeling and tracking with MRI.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Cell Tracking; Contrast Media; Gadolinium; Glioblastoma; Magnetic Resonance Imaging; Male; Metal Nanoparticles; Mice; Particle Size; Polyethylene Glycols; Rats; Transplantation, Heterologous | 2012 |